Enanta Stock Drops After Mixed Results from RSV Drug Trial

Enanta Pharmaceuticals' experimental RSV drug caused stock market disappointment after failing its main goal (reducing symptom time). However, the trial showed success in important secondary areas, like clearing the virus faster.